Phase II study of everolimus (EVL) and octreotide (OCT) LAR in patients with non-functioning gastrointestinal neuroendocrine tumours (GI-NETs): EVERLAR study

Authors :: Jorge Barriuso
Ignacio Matos
Rocio Garcia-Carbonero
Jose Luis Manzano
E. Dotor
Oriol Casanovas
Jaume Capdevila
C. Lopez
Alexandre Teule
Vicente Alonso
Ana Custodio
R. Salazar
Daniel Castellano
Source :: Annals of Oncology. 27:vi145
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: medicine.medical_specialty
Pathology
Everolimus
business.industry
Octreotide
Phases of clinical research
Hematology
Gastroenterology
Oncology
Internal medicine
medicine
In patient
business
medicine.drug

Full Text Access

Tools